Ingalls & Snyder LLC’s P3 Health Partners PIII Stock Holding History

Ingalls & Snyder LLC’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200	Closed	-$2K	–	484
2025 Q1	$2K	Hold	200	–	–	﹤0.01%	456
2024 Q4	$2K	Hold	200	–	–	﹤0.01%	448
2024 Q3	$4K	Hold	200	–	–	﹤0.01%	460
2024 Q2	$5K	Hold	200	–	–	﹤0.01%	434
2024 Q1	$10K	Hold	200	–	–	﹤0.01%	446
2023 Q4	$14K	Hold	200	–	–	﹤0.01%	436
2023 Q3	$15K	Hold	200	–	–	﹤0.01%	433
2023 Q2	$30K	Hold	200	–	–	﹤0.01%	425
2023 Q1	$11K	Hold	200	–	–	﹤0.01%	432
2022 Q4	$18K	Hold	200	–	–	﹤0.01%	438
2022 Q3	$46K	Hold	200	–	–	﹤0.01%	424
2022 Q2	$37K	Hold	200	–	–	﹤0.01%	443
2022 Q1	$78K	Hold	200	–	–	﹤0.01%	452
2021 Q4	$70K	Buy	+200	New	+$95.4K	﹤0.01%	460

Other funds holding PIII

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

TFA

Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ingalls & Snyder LLC's PIII Position: Q2 2025 in Review

Ingalls & Snyder LLC sold out of P3 Health Partners (PIII) in Q2 2025, closing a stake of 200 shares — an estimated $2K sold.

Ingalls & Snyder LLC first reported a position in PIII in Q4 2021 and held it in 14 quarters. The position peaked at $78K in Q1 2022. 16 funds tracked by Wall St. Rank hold PIII as of Q2 2025.

Ingalls & Snyder LLC reported no remaining P3 Health Partners position as of Q2 2025 after selling out during the quarter.
Ingalls & Snyder LLC sold 200 P3 Health Partners shares in Q2 2025, an estimated $2K.
Ingalls & Snyder LLC first reported a position in P3 Health Partners in Q4 2021 and held it in 14 quarters.
Ingalls & Snyder LLC's P3 Health Partners position peaked at $78K in Q1 2022.
16 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2025.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2025, filed 31 Jul 2025.